You thought you were just getting a prescription for hair loss or weight loss in the privacy of your home. You thought the intake forms, the questions about your anxiety, your sexual health, your deepest insecurities, were protected by the same laws that protect you at a physical doctor’s office. You were wrong.
Your doctor took an oath to do no harm. The app you downloaded to fix your sex life or shed a few pounds took a vow to maximize ad revenue.
The FTC just dropped the hammer on Hims & Hers, exposing a reality so grim it should make you immediately delete every health app on your phone. The complaint is damning: Hims & Hers was caught sharing deeply sensitive user data—details about weight loss, sexual health, and mental health—with third-party ad networks like Facebook and Snapchat.
But let’s be clear: this isn’t just a technical privacy breach. It’s not a bug in the code. It is the entire business model.
We watched the direct-to-consumer telehealth boom over the last few years and marveled at the convenience. No awkward waiting rooms. No judgment. Just a few taps on your phone and your medication arrives in a sleek, pastel package. It felt like magic. But as the FTC’s action reveals, that magic was just an illusion built on a foundation of silent exploitation.
Convenience in modern healthcare isn’t a free feature; it’s a transaction where your most intimate data is the currency.
How do you think these companies acquired millions of users so fast? They didn’t buy billboards. They used hyper-targeted advertising. And to target effectively, to know exactly who needs erectile dysfunction meds or anti-anxiety pills, the ad platforms need data. Lots of it. The FTC alleges Hims & Hers gave it to them, breaking promises of privacy and flat-out lying to consumers about how they handled health information.
The tension here is fatal to the illusion. Telehealth companies promise a safe, confidential space. But their growth strategies depend entirely on feeding the surveillance capitalism machine. They need to tell ad platforms who you are, what you’re insecure about, and what you’re buying, so those platforms can find ten thousand more people just like you.
You cannot build a billion-dollar healthcare empire on the promise of trust if your entire customer acquisition strategy relies on quietly betraying it.
Look at the history. Consumer complaints against Hims & Hers already include sneak billing, undisclosed automatic renewals, impossible cancelations, and unlicensed compounding. The FTC lawsuit is just the latest symptom of a company that views users as data points to be monetized, not patients to be treated.
If you use these services, your most private health information is the product being sold. The FTC is stepping in, but the damage is already done. The trust is broken.
The next time you see a slick ad for a telehealth app promising to fix your life with a quick prescription, remember what that convenience actually costs. The healthcare revolution we were promised wasn’t about democratizing medicine—it was about data harvesting in a white coat.
FAQ
Q: Isn't this just a standard privacy breach?
A: No, it's a feature of the business model. Telehealth companies need to feed ad networks to grow, making data exploitation a core revenue strategy, not an accidental oversight.
Q: What does this mean for me if I use these apps?
A: If you use DTC health apps, your sensitive medical data—mental health, weight, sexual health—has likely been packaged and shared with advertisers like Facebook without your informed consent.
Q: Is direct-to-consumer telehealth fundamentally broken?
A: The current venture-backed version is. When healthcare is optimized for rapid user acquisition and ad targeting rather than patient care, privacy is always the first casualty.